EGFR and neoplasm: Though only a few receptors or ligands on tumor cell surface have been suggested as candidates for ST3GAL6, until recently a study indicated that ST3GAL6 was required for the α2,3-sialylation of EGFR, but not that of integrin β1 in HeLa cells by knockout approach 35.